| Aug 6, 2019 |
Aug 8, 2019 |
Vyome Holdings, Inc
|
10% Owner |
Buy |
100.0
|
+250,000
|
44.37%
|
✗
|
$1M |
| Mar 19, 2019 |
Mar 21, 2019 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
20.0
|
-1,115,053
|
-99.26%
|
✗
|
$685.6K |
| Aug 23, 2018 |
Aug 27, 2018 |
Vyome Holdings, Inc
|
10% Owner |
Buy |
100.0
|
+1,648,359
|
41.35%
|
✗
|
$3M |
| Aug 23, 2018 |
Aug 27, 2018 |
Bionano Genomics, Inc.
|
10% Owner |
Buy |
82.5
|
+15,000
|
1.61%
|
✗
|
$91.9K |
| Jan 24, 2018 |
Jan 26, 2018 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
17.5
|
-867,960
|
-28.49%
|
✗
|
$1.3M |
| Dec 6, 2017 |
Dec 8, 2017 |
Esperion Therapeutics, Inc.
|
Director |
Sell |
20.0
|
-365,206
|
-15.86%
|
✗
|
$502.2K |
| May 26, 2016 |
May 27, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
26.3
|
-5,880
|
-36.28%
|
✗
|
$27.6K |
| May 26, 2016 |
May 27, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
17.5
|
-344,120
|
-36.21%
|
✗
|
$1.6M |
| Apr 25, 2016 |
Apr 27, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
37.5
|
-82
|
-0.50%
|
✗
|
$415.4 |
| Apr 25, 2016 |
Apr 27, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
36.3
|
-5,095
|
-0.53%
|
✗
|
$25.8K |
| Apr 19, 2016 |
Apr 21, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
27.5
|
-708
|
-4.17%
|
✗
|
$3.8K |
| Apr 19, 2016 |
Apr 21, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
22.5
|
-41,478
|
-4.16%
|
✗
|
$222K |
| Apr 11, 2016 |
Apr 13, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
45.0
|
-75
|
-0.44%
|
✗
|
$391.5 |
| Apr 11, 2016 |
Apr 13, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
43.8
|
-4,348
|
-0.43%
|
✗
|
$22.7K |
| Apr 6, 2016 |
Apr 8, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
27.5
|
-874
|
-4.87%
|
✗
|
$4.6K |
| Apr 6, 2016 |
Apr 8, 2016 |
Evoke Pharma Inc
|
10% Owner |
Sell |
20.0
|
-51,004
|
-4.85%
|
✗
|
$269.2K |
| Aug 18, 2015 |
Aug 20, 2015 |
Evoke Pharma Inc
|
10% Owner |
Sell |
27.5
|
-202
|
-1.11%
|
✗
|
$1.4K |
| Aug 18, 2015 |
Aug 20, 2015 |
Evoke Pharma Inc
|
10% Owner |
Sell |
22.5
|
-11,836
|
-1.11%
|
✗
|
$83.1K |
| Apr 14, 2015 |
Apr 16, 2015 |
Evoke Pharma Inc
|
10% Owner |
Sell |
20.0
|
-50,163
|
-4.50%
|
✗
|
$365.7K |
| Apr 14, 2015 |
Apr 16, 2015 |
Evoke Pharma Inc
|
10% Owner |
Sell |
27.5
|
-857
|
-4.51%
|
✗
|
$6.2K |
| Nov 25, 2014 |
Dec 10, 2014 |
Evofem Biosciences, Inc.
|
10% Owner |
Sell |
26.3
|
-2,683
|
-2.75%
|
✗
|
$37.6K |
| Nov 25, 2014 |
Dec 10, 2014 |
Evofem Biosciences, Inc.
|
10% Owner |
Sell |
27.5
|
-87,317
|
-0.95%
|
✗
|
$1.2M |
| Nov 25, 2014 |
Nov 26, 2014 |
Evofem Biosciences, Inc.
|
10% Owner |
Sell |
26.3
|
-2,683
|
-2.75%
|
✗
|
$37.6K |
| Nov 25, 2014 |
Nov 26, 2014 |
Evofem Biosciences, Inc.
|
10% Owner |
Sell |
27.5
|
-87,317
|
-0.95%
|
✗
|
$1.2M |
| Oct 21, 2014 |
Oct 21, 2014 |
Esperion Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+500,000
|
24.19%
|
✗
|
$10M |
| May 1, 2014 |
May 5, 2014 |
Aldeyra Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-78,126
|
-1.97%
|
✗
|
$625K |
| Jul 1, 2013 |
Jul 2, 2013 |
Esperion Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+285,714
|
15.73%
|
✗
|
$4M |